این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
چهارشنبه 20 خرداد 1405
Iranian Biomedical Journal
، جلد ۲۹، شماره ۵، صفحات ۳۰۹-۳۲۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Helicobacter pylori Dihydroorotate Dehydrogenase: a Promising Target for Screening Potential Drug Candidates
چکیده انگلیسی مقاله
Background:
De novo pyrimidine biosynthesis is essential for the survival of all living organisms. DHODH catalyzes the fourth step in this pathway. Inhibition of DHODH induces pyrimidine depletion and effectively eradicates microorganisms like
H. pylori
, which lacks the pyrimidine salvage pathway. Herein, we expressed rHp-DHODH, characterized its enzymatic activity, kinetics, and stability, and subsequently evaluated its inhibition by HQNO.
Methods:
The gene fragment encoding the rHp-DHODH protein was synthesized, subcloned, and expressed in soluble form. The recombinant protein was purified, its identity was confirmed, and its activity was measured using a colorimetric reduction assay. Kinetic parameters and the effects of pH, temperature, and incubation time on the enzymatic activity were investigated. The inhibitory effect of HQNO on rHp-DHODH was evaluated using the DCIP reduction assay. The MIC of HQNO against
H. pylori
was determined, and its bactericidal/bacteriostatic effect was assessed.
Results:
Optimal soluble expression of
rHp-DHODH
was achieved in
BL21(DE3)pLysS
. The enzyme exhibited a specific activity of 5.7 U/mg. Maximum activity was observed at pH 8.0 in Tris-HCl buffer at 25 °C. The K
m
values were 39.75 µM for DHO and 5.37 µM for CoQ10, with a k
cat
of
3.82 s
-
¹. The IC
50
of HQNO against the recombinant enzyme was determined as 1.75 μM. HQNO inhibited
H. pylori
growth with an MIC of 0.5-1.0 µg/mL, displaying concentration-dependent bacteriostatic to bactericidal effects.
Conclusions:
The
rHp-DHODH
and its optimized enzymatic assay provide a reliable platform for screening candidate inhibitors, such as HQNO, advancing drug development efforts against
H. pylori
infection.
کلیدواژههای انگلیسی مقاله
Dihydroorotate dehydrogenase, Enzymes, Kinetics
نویسندگان مقاله
| Saba Ghaffari
Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
| Maryam Esmaeili
Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
| Fatemeh Ayoubnejad
Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
| Yeganeh Talebkhan
Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
| Marjan Mohammadi
Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
نشانی اینترنتی
http://ibj.pasteur.ac.ir/browse.php?a_code=A-10-670-11&slc_lang=en&sid=1
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
Medical Biotechnology
نوع مقاله منتشر شده
مقاله کامل
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات